| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 26624* | 2014 |
| Effects of torcetrapib in patients at high risk for coronary events PJ Barter, M Caulfield, M Eriksson, SM Grundy, JJP Kastelein, M Komajda, ... New England journal of medicine 357 (21), 2109-2122, 2007 | 3976 | 2007 |
| Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ... New England Journal of Medicine 380 (1), 11-22, 2019 | 3836 | 2019 |
| Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index EK Speliotes, CJ Willer, SI Berndt, KL Monda, G Thorleifsson, AU Jackson, ... Nature genetics 42 (11), 937-948, 2010 | 3801 | 2010 |
| Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ... Jama 295 (13), 1556-1565, 2006 | 3228 | 2006 |
| Efficacy and safety of low-dose colchicine after myocardial infarction JC Tardif, S Kouz, DD Waters, OF Bertrand, R Diaz, AP Maggioni, FJ Pinto, ... New England journal of medicine 381 (26), 2497-2505, 2019 | 3195 | 2019 |
| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 2923 | 2015 |
| Effects of dalcetrapib in patients with a recent acute coronary syndrome GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ... New England Journal of Medicine 367 (22), 2089-2099, 2012 | 2494 | 2012 |
| Defining the role of common variation in the genomic and biological architecture of adult human height AR Wood, T Esko, J Yang, S Vedantam, TH Pers, S Gustafsson, AY Chu, ... Nature genetics 46 (11), 1173-1186, 2014 | 2289 | 2014 |
| Mannheim carotid intima-media thickness and Plaque consensus (2004–2006–2011) an update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at … PJ Touboul, MG Hennerici, S Meairs, H Adams, P Amarenco, N Bornstein, ... Cerebrovascular diseases 34 (4), 290-296, 2012 | 2235 | 2012 |
| Mannheim carotid intima-media thickness consensus (2004–2006) an update on behalf of the advisory board of the 3rd and 4th watching the risk symposium 13th and 15th European … PJ Touboul, MG Hennerici, S Meairs, H Adams, P Amarenco, N Bornstein, ... Cerebrovascular diseases 23 (1), 75-80, 2007 | 1940 | 2007 |
| ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association … LA Fleisher, JA Beckman, KA Brown, H Calkins, EL Chaikof, ... Journal of the American College of Cardiology 50 (17), e159-e242, 2007 | 1922 | 2007 |
| Resting heart rate in cardiovascular disease K Fox, JS Borer, AJ Camm, N Danchin, R Ferrari, JLL Sendon, PG Steg, ... Journal of the American College of Cardiology 50 (9), 823-830, 2007 | 1477 | 2007 |
| Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease A Diaz, MG Bourassa, MC Guertin, JC Tardif European heart journal 26 (10), 967-974, 2005 | 1365 | 2005 |
| Effect of torcetrapib on the progression of coronary atherosclerosis SE Nissen, JC Tardif, SJ Nicholls, JH Revkin, CL Shear, WT Duggan, ... New England journal of medicine 356 (13), 1304-1316, 2007 | 1222 | 2007 |
| Lipoprotein (a) reduction in persons with cardiovascular disease S Tsimikas, E Karwatowska-Prokopczuk, I Gouni-Berthold, JC Tardif, ... New England Journal of Medicine 382 (3), 244-255, 2020 | 1054 | 2020 |
| The power of genetic diversity in genome-wide association studies of lipids SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ... Nature 600 (7890), 675-679, 2021 | 926 | 2021 |
| Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina JC Tardif, I Ford, M Tendera, MG Bourassa, K Fox European heart journal 26 (23), 2529-2536, 2005 | 922 | 2005 |
| Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials E Vermes, JC Tardif, MG Bourassa, N Racine, S Levesque, M White, ... Circulation 107 (23), 2926-2931, 2003 | 891 | 2003 |
| Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial J Dupuis, JC Tardif, P Cernacek, P Théroux Circulation 99 (25), 3227-3233, 1999 | 845 | 1999 |
